Industry Research Reports

Home > Reports > Medical Care > In Vitro Diagnostic Kit Raw Materials- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

In Vitro Diagnostic Kit Raw Materials- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Care

Published Date: 2025-01-13

Pages: 128 Pages

Report ld: 3499674

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

In Vitro Diagnostic Kit Raw Materials Market Size(US$)

CAGR 2025-2031

5.7%

Market Size,2031

USD 20,590

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 14,760 million

Market Forecast in 2031(Value)

US$ 20,590 million

CAGR

5.7%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for In Vitro Diagnostic Kit Raw Materials was estimated to be worth US$ 14040 million in 2024 and is forecast to a readjusted size of US$ 20590 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.

The core raw materials of in vitro diagnostic (IVD) reagents / kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents / kits. Although there are a variety of commercially available products in raw material market, it is difficult to meet all the needs from IVD reagent manufacturers.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostic Kit Raw Materials, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In Vitro Diagnostic Kit Raw Materials by region & country, by Type, and by Application.

The In Vitro Diagnostic Kit Raw Materials market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostic Kit Raw Materials.

Market Segmentation

By Company

Thermo Fisher
Hytest
BBI Solution
Meridian
Merck
Roche
TOYOBO
Sekisui Diagnostic
Meikang Bio
Anke Bio
Human Wellbeing Medicine
Norwegian
GenScript
Feipeng Bio
Bumrungrad Bio
Apis Bio

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Antigens and Antibodies
Enzymes and Coenzymes
Other

Segment by Application

Immunodiagnostic Reagents
Chemical Diagnostic Reagents
Molecular Diagnostic Reagents
Point-of-care Reagents
Other

biaoTi Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of In Vitro Diagnostic Kit Raw Materials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of In Vitro Diagnostic Kit Raw Materials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of In Vitro Diagnostic Kit Raw Materials in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 In Vitro Diagnostic Kit Raw Materials Product Introduction

1.2 Global In Vitro Diagnostic Kit Raw Materials Market Size Forecast (2020-2031)

1.3 In Vitro Diagnostic Kit Raw Materials Market Trends & Drivers

1.3.1 In Vitro Diagnostic Kit Raw Materials Industry Trends

1.3.2 In Vitro Diagnostic Kit Raw Materials Market Drivers & Opportunity

1.3.3 In Vitro Diagnostic Kit Raw Materials Market Challenges

1.3.4 In Vitro Diagnostic Kit Raw Materials Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global In Vitro Diagnostic Kit Raw Materials Players Revenue Ranking (2024)

2.2 Global In Vitro Diagnostic Kit Raw Materials Revenue by Company (2020-2025)

2.3 Key Companies In Vitro Diagnostic Kit Raw Materials Manufacturing Base Distribution and Headquarters

2.4 Key Companies In Vitro Diagnostic Kit Raw Materials Product Offered

2.5 Key Companies Time to Begin Mass Production of In Vitro Diagnostic Kit Raw Materials

2.6 In Vitro Diagnostic Kit Raw Materials Market Competitive Analysis

2.6.1 In Vitro Diagnostic Kit Raw Materials Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by In Vitro Diagnostic Kit Raw Materials Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic Kit Raw Materials as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antigens and Antibodies

3.1.2 Enzymes and Coenzymes

3.1.3 Other

3.2 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Type

3.2.1 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global In Vitro Diagnostic Kit Raw Materials Sales Value, by Type (2020-2031)

3.2.3 Global In Vitro Diagnostic Kit Raw Materials Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Immunodiagnostic Reagents

4.1.2 Chemical Diagnostic Reagents

4.1.3 Molecular Diagnostic Reagents

4.1.4 Point-of-care Reagents

4.1.5 Other

4.2 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Application

4.2.1 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global In Vitro Diagnostic Kit Raw Materials Sales Value, by Application (2020-2031)

4.2.3 Global In Vitro Diagnostic Kit Raw Materials Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region

5.1.1 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (2020-2025)

5.1.3 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (2026-2031)

5.1.4 Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

5.2.2 North America In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

5.3.2 Europe In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

5.4.2 Asia Pacific In Vitro Diagnostic Kit Raw Materials Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

5.5.2 South America In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

5.6.2 Middle East & Africa In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions In Vitro Diagnostic Kit Raw Materials Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.3 United States

6.3.1 United States In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.3.2 United States In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.3.3 United States In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.4.2 Europe In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.5.2 China In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.5.3 China In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.6.2 Japan In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.7.2 South Korea In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.8.2 Southeast Asia In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India In Vitro Diagnostic Kit Raw Materials Sales Value, 2020-2031

6.9.2 India In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

6.9.3 India In Vitro Diagnostic Kit Raw Materials Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Thermo Fisher

7.1.1 Thermo Fisher Profile

7.1.2 Thermo Fisher Main Business

7.1.3 Thermo Fisher In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.1.4 Thermo Fisher In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.1.5 Thermo Fisher Recent Developments

7.2 Hytest

7.2.1 Hytest Profile

7.2.2 Hytest Main Business

7.2.3 Hytest In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.2.4 Hytest In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.2.5 Hytest Recent Developments

7.3 BBI Solution

7.3.1 BBI Solution Profile

7.3.2 BBI Solution Main Business

7.3.3 BBI Solution In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.3.4 BBI Solution In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.3.5 BBI Solution Recent Developments

7.4 Meridian

7.4.1 Meridian Profile

7.4.2 Meridian Main Business

7.4.3 Meridian In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.4.4 Meridian In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.4.5 Meridian Recent Developments

7.5 Merck

7.5.1 Merck Profile

7.5.2 Merck Main Business

7.5.3 Merck In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.5.4 Merck In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.5.5 Merck Recent Developments

7.6 Roche

7.6.1 Roche Profile

7.6.2 Roche Main Business

7.6.3 Roche In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.6.4 Roche In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.6.5 Roche Recent Developments

7.7 TOYOBO

7.7.1 TOYOBO Profile

7.7.2 TOYOBO Main Business

7.7.3 TOYOBO In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.7.4 TOYOBO In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.7.5 TOYOBO Recent Developments

7.8 Sekisui Diagnostic

7.8.1 Sekisui Diagnostic Profile

7.8.2 Sekisui Diagnostic Main Business

7.8.3 Sekisui Diagnostic In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.8.4 Sekisui Diagnostic In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.8.5 Sekisui Diagnostic Recent Developments

7.9 Meikang Bio

7.9.1 Meikang Bio Profile

7.9.2 Meikang Bio Main Business

7.9.3 Meikang Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.9.4 Meikang Bio In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.9.5 Meikang Bio Recent Developments

7.10 Anke Bio

7.10.1 Anke Bio Profile

7.10.2 Anke Bio Main Business

7.10.3 Anke Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.10.4 Anke Bio In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.10.5 Anke Bio Recent Developments

7.11 Human Wellbeing Medicine

7.11.1 Human Wellbeing Medicine Profile

7.11.2 Human Wellbeing Medicine Main Business

7.11.3 Human Wellbeing Medicine In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.11.4 Human Wellbeing Medicine In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.11.5 Human Wellbeing Medicine Recent Developments

7.12 Norwegian

7.12.1 Norwegian Profile

7.12.2 Norwegian Main Business

7.12.3 Norwegian In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.12.4 Norwegian In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.12.5 Norwegian Recent Developments

7.13 GenScript

7.13.1 GenScript Profile

7.13.2 GenScript Main Business

7.13.3 GenScript In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.13.4 GenScript In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.13.5 GenScript Recent Developments

7.14 Feipeng Bio

7.14.1 Feipeng Bio Profile

7.14.2 Feipeng Bio Main Business

7.14.3 Feipeng Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.14.4 Feipeng Bio In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.14.5 Feipeng Bio Recent Developments

7.15 Bumrungrad Bio

7.15.1 Bumrungrad Bio Profile

7.15.2 Bumrungrad Bio Main Business

7.15.3 Bumrungrad Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.15.4 Bumrungrad Bio In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.15.5 Bumrungrad Bio Recent Developments

7.16 Apis Bio

7.16.1 Apis Bio Profile

7.16.2 Apis Bio Main Business

7.16.3 Apis Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

7.16.4 Apis Bio In Vitro Diagnostic Kit Raw Materials Revenue (US$ Million) & (2020-2025)

7.16.5 Apis Bio Recent Developments

8 Industry Chain Analysis

8.1 In Vitro Diagnostic Kit Raw Materials Industrial Chain

8.2 In Vitro Diagnostic Kit Raw Materials Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 In Vitro Diagnostic Kit Raw Materials Sales Model

8.5.2 Sales Channel

8.5.3 In Vitro Diagnostic Kit Raw Materials Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. In Vitro Diagnostic Kit Raw Materials Market Trends

Table 2. In Vitro Diagnostic Kit Raw Materials Market Drivers & Opportunity

Table 3. In Vitro Diagnostic Kit Raw Materials Market Challenges

Table 4. In Vitro Diagnostic Kit Raw Materials Market Restraints

Table 5. Global In Vitro Diagnostic Kit Raw Materials Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global In Vitro Diagnostic Kit Raw Materials Revenue Market Share by Company (2020-2025)

Table 7. Key Companies In Vitro Diagnostic Kit Raw Materials Manufacturing Base Distribution and Headquarters

Table 8. Key Companies In Vitro Diagnostic Kit Raw Materials Product Type

Table 9. Key Companies Time to Begin Mass Production of In Vitro Diagnostic Kit Raw Materials

Table 10. Global In Vitro Diagnostic Kit Raw Materials Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic Kit Raw Materials as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global In Vitro Diagnostic Kit Raw Materials Sales Market Share in Value by Type (2020-2025)

Table 17. Global In Vitro Diagnostic Kit Raw Materials Sales Market Share in Value by Type (2026-2031)

Table 18. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global In Vitro Diagnostic Kit Raw Materials Sales Market Share in Value by Application (2020-2025)

Table 22. Global In Vitro Diagnostic Kit Raw Materials Sales Market Share in Value by Application (2026-2031)

Table 23. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (2020-2025) & (%)

Table 27. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions In Vitro Diagnostic Kit Raw Materials Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions In Vitro Diagnostic Kit Raw Materials Sales Value, (2026-2031) & (US$ Million)

Table 31. Thermo Fisher Basic Information List

Table 32. Thermo Fisher Description and Business Overview

Table 33. Thermo Fisher In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 34. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Thermo Fisher (2020-2025)

Table 35. Thermo Fisher Recent Developments

Table 36. Hytest Basic Information List

Table 37. Hytest Description and Business Overview

Table 38. Hytest In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 39. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Hytest (2020-2025)

Table 40. Hytest Recent Developments

Table 41. BBI Solution Basic Information List

Table 42. BBI Solution Description and Business Overview

Table 43. BBI Solution In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 44. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of BBI Solution (2020-2025)

Table 45. BBI Solution Recent Developments

Table 46. Meridian Basic Information List

Table 47. Meridian Description and Business Overview

Table 48. Meridian In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 49. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Meridian (2020-2025)

Table 50. Meridian Recent Developments

Table 51. Merck Basic Information List

Table 52. Merck Description and Business Overview

Table 53. Merck In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 54. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Merck (2020-2025)

Table 55. Merck Recent Developments

Table 56. Roche Basic Information List

Table 57. Roche Description and Business Overview

Table 58. Roche In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 59. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Roche (2020-2025)

Table 60. Roche Recent Developments

Table 61. TOYOBO Basic Information List

Table 62. TOYOBO Description and Business Overview

Table 63. TOYOBO In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 64. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of TOYOBO (2020-2025)

Table 65. TOYOBO Recent Developments

Table 66. Sekisui Diagnostic Basic Information List

Table 67. Sekisui Diagnostic Description and Business Overview

Table 68. Sekisui Diagnostic In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 69. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Sekisui Diagnostic (2020-2025)

Table 70. Sekisui Diagnostic Recent Developments

Table 71. Meikang Bio Basic Information List

Table 72. Meikang Bio Description and Business Overview

Table 73. Meikang Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 74. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Meikang Bio (2020-2025)

Table 75. Meikang Bio Recent Developments

Table 76. Anke Bio Basic Information List

Table 77. Anke Bio Description and Business Overview

Table 78. Anke Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 79. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Anke Bio (2020-2025)

Table 80. Anke Bio Recent Developments

Table 81. Human Wellbeing Medicine Basic Information List

Table 82. Human Wellbeing Medicine Description and Business Overview

Table 83. Human Wellbeing Medicine In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 84. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Human Wellbeing Medicine (2020-2025)

Table 85. Human Wellbeing Medicine Recent Developments

Table 86. Norwegian Basic Information List

Table 87. Norwegian Description and Business Overview

Table 88. Norwegian In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 89. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Norwegian (2020-2025)

Table 90. Norwegian Recent Developments

Table 91. GenScript Basic Information List

Table 92. GenScript Description and Business Overview

Table 93. GenScript In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 94. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of GenScript (2020-2025)

Table 95. GenScript Recent Developments

Table 96. Feipeng Bio Basic Information List

Table 97. Feipeng Bio Description and Business Overview

Table 98. Feipeng Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 99. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Feipeng Bio (2020-2025)

Table 100. Feipeng Bio Recent Developments

Table 101. Bumrungrad Bio Basic Information List

Table 102. Bumrungrad Bio Description and Business Overview

Table 103. Bumrungrad Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 104. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Bumrungrad Bio (2020-2025)

Table 105. Bumrungrad Bio Recent Developments

Table 106. Apis Bio Basic Information List

Table 107. Apis Bio Description and Business Overview

Table 108. Apis Bio In Vitro Diagnostic Kit Raw Materials Products, Services and Solutions

Table 109. Revenue (US$ Million) in In Vitro Diagnostic Kit Raw Materials Business of Apis Bio (2020-2025)

Table 110. Apis Bio Recent Developments

Table 111. Key Raw Materials Lists

Table 112. Raw Materials Key Suppliers Lists

Table 113. In Vitro Diagnostic Kit Raw Materials Downstream Customers

Table 114. In Vitro Diagnostic Kit Raw Materials Distributors List

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. In Vitro Diagnostic Kit Raw Materials Product Picture

Figure 2. Global In Vitro Diagnostic Kit Raw Materials Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global In Vitro Diagnostic Kit Raw Materials Sales Value (2020-2031) & (US$ Million)

Figure 4. In Vitro Diagnostic Kit Raw Materials Report Years Considered

Figure 5. Global In Vitro Diagnostic Kit Raw Materials Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by In Vitro Diagnostic Kit Raw Materials Revenue in 2024

Figure 7. In Vitro Diagnostic Kit Raw Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Antigens and Antibodies Picture

Figure 9. Enzymes and Coenzymes Picture

Figure 10. Other Picture

Figure 11. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 12. Global In Vitro Diagnostic Kit Raw Materials Sales Value Market Share by Type, 2024 & 2031

Figure 13. Product Picture of Immunodiagnostic Reagents

Figure 14. Product Picture of Chemical Diagnostic Reagents

Figure 15. Product Picture of Molecular Diagnostic Reagents

Figure 16. Product Picture of Point-of-care Reagents

Figure 17. Product Picture of Other

Figure 18. Global In Vitro Diagnostic Kit Raw Materials Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 19. Global In Vitro Diagnostic Kit Raw Materials Sales Value Market Share by Application, 2024 & 2031

Figure 20. North America In Vitro Diagnostic Kit Raw Materials Sales Value (2020-2031) & (US$ Million)

Figure 21. North America In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

Figure 22. Europe In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 23. Europe In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

Figure 24. Asia Pacific In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 25. Asia Pacific In Vitro Diagnostic Kit Raw Materials Sales Value by Region (%), 2024 VS 2031

Figure 26. South America In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 27. South America In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

Figure 28. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 29. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Sales Value by Country (%), 2024 VS 2031

Figure 30. Key Countries/Regions In Vitro Diagnostic Kit Raw Materials Sales Value (%), (2020-2031)

Figure 31. United States In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 32. United States In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 33. United States In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 34. Europe In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 35. Europe In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 36. Europe In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 37. China In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 38. China In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 39. China In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 40. Japan In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 41. Japan In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 42. Japan In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 43. South Korea In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 44. South Korea In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 45. South Korea In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 46. Southeast Asia In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 47. Southeast Asia In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 48. Southeast Asia In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 49. India In Vitro Diagnostic Kit Raw Materials Sales Value, (2020-2031) & (US$ Million)

Figure 50. India In Vitro Diagnostic Kit Raw Materials Sales Value by Type (%), 2024 VS 2031

Figure 51. India In Vitro Diagnostic Kit Raw Materials Sales Value by Application (%), 2024 VS 2031

Figure 52. In Vitro Diagnostic Kit Raw Materials Industrial Chain

Figure 53. In Vitro Diagnostic Kit Raw Materials Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

Related Reports

Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2024
The core raw materials of in vitro diagnostic (IVD) reagents / kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents / kits. Although there are a variety of commercially available products in raw material market, it is difficult to meet all the needs from IVD reagent manufacturers.
Published Date: 2024-01-18
Pages: 92
USD 2900.00
(Single User License)
Global In Vitro Diagnostic Kit Raw Materials Market Insights, Forecast to 2030
The core raw materials of in vitro diagnostic (IVD) reagents / kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents / kits. Although there are a variety of commercially available products in raw material market, it is difficult to meet all the needs from IVD reagent manufacturers.
Published Date: 2024-04-15
Pages: 114
USD 4900.00
(Single User License)
Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2025
The global market for In Vitro Diagnostic Kit Raw Materials was valued at US$ 14040 million in the year 2024 and is projected to reach a revised size of US$ 20590 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published Date: 2025-01-13
Pages: 100
USD 2900.00
(Single User License)

Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2024
The core raw materials of in vitro diagnostic (IVD) reagents / kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents / kits. Although there are a variety of commercially available products in raw material market, it is difficult to meet all the needs from IVD reagent manufacturers.
Published: 2024-01-18
Pages: 92
USD 2900.00 (Single User License)
Global In Vitro Diagnostic Kit Raw Materials Market Insights, Forecast to 2030
The core raw materials of in vitro diagnostic (IVD) reagents / kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents / kits. Although there are a variety of commercially available products in raw material market, it is difficult to meet all the needs from IVD reagent manufacturers.
Published: 2024-04-15
Pages: 114
USD 4900.00 (Single User License)
Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2025
The global market for In Vitro Diagnostic Kit Raw Materials was valued at US$ 14040 million in the year 2024 and is projected to reach a revised size of US$ 20590 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published: 2025-01-13
Pages: 100
USD 2900.00 (Single User License)